US2020061359A1PendingUtilityA1
Microneedle Device
Assignee: HISAMITSU PHARMACEUTICAL COPriority: Sep 11, 2014Filed: Oct 30, 2019Published: Feb 27, 2020
Est. expirySep 11, 2034(~8.1 yrs left)· nominal 20-yr term from priority
A61M 37/00A61M 37/0015A61M 2037/0023A61L 31/16A61K 9/0021A61L 2300/252A61K 47/183A61M 2037/0053A61L 31/08A61M 2037/0046B05D 3/0254
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a microneedle device comprising: a substrate; a microneedle disposed on the substrate; and a coating layer formed on the microneedle; wherein the coating layer comprises a physiologically active substance, arginine, and glycerin.
Claims
exact text as granted — not AI-modified1 - 9 . (canceled)
10 . A method for producing a microneedle device comprising the steps of:
providing a microneedle array comprising a substrate and a microneedle; mixing a physiologically active substance, arginine, and glycerin to obtain a coating composition; coating the microneedle with the coating composition; and drying the coating composition to form a coating layer on the microneedle.
11 . The method according to claim 10 , wherein the coating composition further contains an acid selected from the group consisting of citric acid, phosphoric acid, boric acid, tartaric acid, and lactic acid.
12 . The method according to claim 10 , wherein the drying is performed until, in the coating layer, the mass of arginine reaches 0.06 to 0.85-fold of the mass of the physiologically active substance and the mass of glycerin reaches 40% or less relative to the mass of the whole coating layer.
13 . The method according to claim 11 , wherein the drying is performed until, in the coating layer, the mass of arginine reaches 0.06 to 0.85-fold of the mass of the physiologically active substance and the mass of glycerin reaches 40% or less relative to the mass of the whole coating layer.Join the waitlist — get patent alerts
Track US2020061359A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.